γ-Tocotrienol inhibits HeLa cell proliferation likely via modulation of the PI3K/AKT/mTOR signaling pathway
Yichun Tian, Xian Wang, Zhaoxin Lu, Yaqing Mi, Shaobo Zhou, Weili Xu · 2026
Read γ-Tocotrienol inhibits HeLa cell proliferation likely via modulation of the PI3K/AKT/mTOR signaling pathway by Yichun Tian, Xian Wang, Zhaoxin Lu, Yaqing Mi, Shaobo Zhou, Weili Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13130507.txt.
Description
A form of vitamin E called gamma-tocotrienol can slow cancer cells, but the route it takes inside them is unsettled. Yichun Tian and co-authors treated human cervical cancer HeLa cells with the compound at several doses. They tracked a major growth pathway, PI3K/AKT/mTOR, and the proteins below it. They also compared the compound with wortmannin, a known blocker of the same pathway, alone and in combination.
The vitamin E form lowered the pathway's activity and cut two growth proteins, cyclin D1 and c-Myc. At a mid-range dose it matched the known blocker's effect. Cells divided less, stalled before copying their DNA, and died more readily. Combining both agents strengthened the effect further. The authors suggest the compound deserves study as a nutrition-linked aid in cancer prevention research.
Catalog record
| CREATOR | Yichun Tian, Xian Wang, Zhaoxin Lu, Yaqing Mi, Shaobo Zhou, Weili Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |